LOS ANGELES–(BUSINESS WIRE)–NavJam LLC today announced an exclusive worldwide sales and distribution agreement granting Ruthless LLC, doing business as Ruthless Spine, the rights to market NavJamโs patented and patent-pending spinal surgery instruments. The agreement covers NavJamโs patented โsmartโ Jamshidi and its upcoming KS Drill Guide for power drills, which are designed to work in tandem with Ruthless Spineโs patented RJBโข technology.
Karlton Spindle, inventor of the patented and FDA 510(k)-cleared NavJam โsmartโ Jamshidi, co-invented the FDA De Novoโapproved RJBโข intraoperative measurement device at Ruthless Spine. He said the new partnership will enable continued innovation. โThis relationship allows me to keep developing new instrumentation and expanding Ruthless Spineโs portfolio,โ said Spindle. โWeโre looking ahead from the Jamshidi to the upcoming NavJam Power Drill Adapter, along with products in development like the KSQ.โ
About the Device โ The patented NavJam โsmartโ Jamshidi works seamlessly with Ruthless Spineโs FDA De Novoโcleared RJBโข intraoperative angle measurement instrument. The RJBโข is a single-use, Bluetooth-connected module that pairs with a tablet to display instrument orientation in real time, eliminating bulky, costly equipment and setup time while dramatically reducing patient exposure to radiation. In clinical use, it has reduced average surgical time by 77 minutes per case while matching the accuracy of traditional navigation systems.
The NavJam extends this innovation to the Jamshidi needle step of lumbosacral pedicle screw placement. Disposable and wirelessly linked to a tablet, it gives surgeons live visual feedback on screw placementโserving as a precise guide rather than a replacement for surgical judgment. Together, the NavJam and RJBโข dramatically reduce radiation exposure, cut costs, and shorten operating time, providing hospitals with a scalable, radiation-sparing alternative to legacy navigation systems.
Ruthless Spine, a self-funded startup based in Irwindale, California, has been disrupting an industry long defined by multimillion-dollar navigation systems built on decades-old technology. Its RJBโข device, FDA De Novoโcleared in 2023, was named Spinal Product of the Year 2023 and remains the only self-funded product in its category with De Novo clearance.
Dr. Shane Pak, co-inventor of the RJBโข and lead surgeon for Ruthless Spine, expressed enthusiasm for the collaboration. โThese devices were engineered to work together,โ said Pak. โOur partnership creates the perfect synergy to deliver this innovative technology to more surgeons who need it.โ
NavJam and Ruthless Spine will be exhibiting at Booth #1150 at the North American Spine Society (NASS) Annual Meeting in Denver, November 14โ16.
About NavJam LLC
NavJam LLC is a Los Angelesโbased MedTech R&D company dedicated to innovating Spinal Surgery. Its FDA-cleared NavJam Jamshidi is a disposable, with pocket for Bluetooth-connected angle measurement instrument for lumbosacral pedicle screw placement that pairs with standard Android or iOS tablets, providing real-time orientation with a 30-second setup and no specialized staff. The companyโs NavJamโข Jamshidi expands this approach to the entry step of screw placement, offering wireless trajectory feedback in a similarly streamlined format.
Ruthless Spine is a Los Angelesโbased MedTech company dedicated to reducing patient radiation and simplifying spine surgery by eliminating capital equipment expense and training burdens of traditional navigation or robots. Its FDA-cleared RJBโข is a disposable, Bluetooth-connected angle measurement instrument for lumbosacral pedicle screw placement that pairs with standard Android or iOS tablets, providing real-time orientation with a 30-second setup and no specialized staff. The companyโs NavJamโข Jamshidi expands this approach to the entry step of screw placement, offering wireless trajectory feedback in a similarly streamlined format. Ruthless Spine holds U.S. and Taiwan patents. Learn more at www.ruthlessspine.com
Contacts
Dan Conley
Beacon Communications
312-593-8461
[email protected]

